eli lilly retatrutide trials phase 3 trial A new clinical trial from Eli Lilly and Company suggests Lilly's next-gen drug shows significant
Description
doi: 10.3390/ijms221910822
Today I want to do a little bit of a review on tirzepatide or Mounjaro, whatever you want to call it
Ships FREE every 2 months - 120 scoops
Keep a simple log of what you eat and when symptoms occur
The present study is significant because it shows that the increase in intestinal NE caused by GLP-1RA is due to the involvement of central nervous system activation in addition to potential peripheral effects of GLP-1
GLP-1 medications can influence several markers, and knowing what to expect helps you interpret results accurately
